| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,663 |
3,345 |
$339K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,133 |
1,867 |
$196K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
455 |
425 |
$21K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
162 |
154 |
$13K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
123 |
90 |
$6K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
605 |
524 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
856 |
377 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
434 |
393 |
$772.16 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
126 |
118 |
$630.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
15 |
14 |
$5.58 |
| 3075F |
|
12 |
12 |
$0.00 |
| 3074F |
|
1,112 |
1,047 |
$0.00 |
| 99000 |
|
19 |
17 |
$0.00 |
| 3079F |
|
13 |
12 |
$0.00 |
| 3078F |
|
1,410 |
1,343 |
$0.00 |
| 3077F |
|
14 |
12 |
$0.00 |